id
processing priority
4
site type
3 (personal blog or private political site, e.g. Blogspot, Substack, also small blogs on own domains)
review version
11
html import
27 (unknown)
first seen date
2024-02-11 06:37:24
expired found date
-
created at
2024-07-01 01:51:57
updated at
2026-02-23 20:01:05
length
25
crc
43552
tld
2211
nm parts
0
nm random digits
0
nm rare letters
0
is subdomain of id
-
previous id
0
replaced with id
0
related id
-
dns primary id
dns alternative id
0
lifecycle status
0 (unclassified, or currently active)
deleted subdomains
0
page imported products
0
page imported random
0
page imported parking
0
count skipped due to recent timeouts on the same server IP
0
count content received but rejected due to 11-799
0
count dns errors
0
count cert errors
0
count timeouts
0
count http 429
0
count http 404
0
count http 403
0
count http 5xx
0
next operation date
-
server bits
—
server ip
-
mp import status
27
mp rejected date
-
mp saved date
-
mp size orig
228291
mp size raw text
78783
mp inner links count
186
mp inner links status
20 (imported)
title
Sufficient Description
description
Observations on Canadian patent cases
image
site name
author
updated
2026-02-21 15:16:11
raw text
Sufficient Description Sufficient Description Observations on Canadian patent cases Monday, February 5, 2024 What Is the Threshold for Influence in Inducement? Apotex Inc v Janssen Inc 2024 FCA 9 Locke JA: de Montigny CJ, Goyette JA affg Janssen Inc v Apotex Inc 2022 FC 107 Manson J 2,655,335 / paliperidone palmitate / INVEGA SUSTENNA / NOC This decision addresses the second prong of the Corlac 2011 FCA 228 [162] test for inducement in the pharma context. In some ways it is perfectly straightforward. Manson J found as a fact that Apotex’s product monograph (PM) was the ‘but for’ cause of direct infringement and the FCA affirmed on that basis. Locke JA’s decision nonetheless raises two notable issues. First, there seems to be an unresolved tension between this decision and Teva v Janssen 2023 FCA 68 as to the standard for influence on the second prong of the Corlac test; while this decision endorses a high threshold of ‘but for’ causation, Teva...
redirect type
0 (-)
block type
0 (no issues)
detected language
1 (English)
category id
index version
1
spam phrases
2
text nonlatin
3
text cyrillic
0
text characters
62517
text words
12998
text unique words
2282
text lines
1371
text sentences
480
text paragraphs
137
text words per sentence
27
text matched phrases
0
text matched dictionaries
0
links self subdomains
0
links other subdomains
62 - decisions.fca-caf.gc.ca, decisions.fct-cf.gc.ca, brevets-patents.ic.gc.ca, papers.ssrn.com, scc-csc.lexum.com, decisions.fca-caf.ca, laws.justice.gc.ca, laws-lois.justice.gc.ca, academic.oup.com, worldwide.espacenet.com, cipo.ic.gc.ca, webprod3.hc-sc.gc.ca, hc-sc.gc.ca
links other domains
13 - wto.org, bailii.org, cambridge.org, floridalawreview.com, unb.ca, epo.org
links spam adult
0
links spam random
0
links spam expired
0
links ext activities
4
links ext ecommerce
0
links ext finance
0
links ext crypto
0
links ext booking
0
links ext news
0
links ext leaks
0
links ext ugc
42 - blogger.com, drive.google.com
links ext klim
0
links ext generic
5
dol status
0
dol updated
2026-02-21 15:16:11
rss path
rss status
0 (new)
rss found date
-
rss size orig
0
rss items
0
rss spam phrases
0
rss detected language
0 (awaiting analysis)
inbefore feed id
-
inbefore status
0 (new)
sitemap path
sitemap status
0 (new)
sitemap review version
2
sitemap urls count
0
sitemap urls adult
0
sitemap filtered products
0
sitemap filtered videos
0
sitemap found date
-
sitemap process date
-
sitemap first import date
-
sitemap last import date
-